| Financial Year |
March 31 2023 |
| Monetary Funds |
358,110,851.11 |
| Held-for-trading Financial Assets |
145,324,561.65 |
| Notes Receivable |
27,334,753.59 |
| Accounts Receivable |
436,853,637.61 |
| Advances to Suppliers |
14,770,166.13 |
| Other Receivables |
11,023,596.36 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
302,855,365.82 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
129,660,087.65 |
| Other Current Assets |
300,482,426.70 |
| Total Current Assets |
1,742,339,775.49 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
256,498,234.39 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
166,700,152.55 |
| Under-construction Projects |
35,027,599.58 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
19,072,630.43 |
| R&D expenses |
-- |
| Goodwill |
8,786,607.06 |
| Long-Term Deferred and Prepaid Expenses |
504,188.14 |
| Deferred Income Tax Assets |
24,250,352.89 |
| Other Non-Current Assets |
71,589,661.79 |
| Sub-Total of Non-Current Assets |
887,607,605.99 |
| Total Assets |
2,629,947,381.48 |
| Short-Term Loans |
20,812,640.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
162,044,035.23 |
| Accounts Payable |
182,157,506.31 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
13,221,291.32 |
| Taxes Payable |
7,030,169.80 |
| Interest Payable |
2,210,921.99 |
| Dividend Payable |
576,240.00 |
| Other payables |
22,868,682.65 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,688,704.33 |
| Other Current Liabilities |
2,099,366.22 |
| Sub-Total of Current Liabilities |
490,151,421.36 |
| Long-term Loans |
99,939,407.01 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
11,830,542.31 |
| Deferred Income Tax Liabilities |
7,571,241.41 |
| Other Non-Current Liabilities |
408,698.67 |
| Sub-Total of Non-Current Liabilities |
139,759,269.15 |
| Total Liabilities |
629,910,690.51 |
| Paid-In Capital(Or Share Stock) |
131,869,930.00 |
| Capital Surplus |
1,139,286,582.49 |
| Surplus Reserve |
81,484,842.30 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
623,209,510.47 |
| Minority Stockholder's Interest |
22,670,464.45 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,977,366,226.52 |
| Owner's Equity（Stockholder's Equity） |
2,000,036,690.97 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,629,947,381.48 |
